Sabzi Niloofar, Moniri Rezvan, Sehat Mojtaba, Fathizadeh Hadis, Nazari-Alam Ali
Department of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Iran J Microbiol. 2022 Dec;14(6):863-873. doi: 10.18502/ijm.v14i6.11261.
In the past few years, application of new antimicrobial e.g. nanoparticles (NPs) to treat infection caused by drug-resistant bacteria has increased. This study aimed to determine antimicrobial property of silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) in combination with linezolid on biofilm.
A total of forty-eight isolates of spp. were collected and confirmed by PCR method. The synthesis of biocompatible AgNPs was performed, then analyzed by Fourier Transform Infrared spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and Transmission Electron Microscopy. We carried out minimum inhibitory concentration (MIC) and biofilm forming capacity of AgNPs and AuNPs with linezolid.
Twenty-two isolates and twentysix investigated in this study. Strong biofilm formation was seen in 12 (25%) of isolates, and others isolates (75%) formed moderate biofilm. AgNPs and Au-NPs size were 26 nm and 20 nm respectively. The MIC of AgNPs was 23.2 μg/ml, and AuNPs were 92.1 μg/ml and the lowest MIC was obtained 2 μg/ml in linezolid. Biofilm formation inhibitory activity by AuNPs + Linezolide and AgNPs + Linezolide 70 to 80 percent increased in average.
The antibiofilm activity of AgNPs and AuNPs increased when both agents were used in combination with linezolid in comparison with each agent alone.
在过去几年中,新型抗菌剂如纳米颗粒(NPs)用于治疗耐药菌感染的应用有所增加。本研究旨在确定银纳米颗粒(AgNPs)和金纳米颗粒(AuNPs)与利奈唑胺联合对生物膜的抗菌特性。
共收集了48株 spp. 菌株,并通过PCR方法进行确认。进行了生物相容性AgNPs的合成,然后通过傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)和透射电子显微镜进行分析。我们测定了AgNPs和AuNPs与利奈唑胺的最低抑菌浓度(MIC)和生物膜形成能力。
本研究中调查了22株 菌株和26株 菌株。在12株(25%)菌株中观察到强烈的生物膜形成,其他菌株(75%)形成中度生物膜。AgNPs和Au-NPs的尺寸分别为26 nm和20 nm。AgNPs的MIC为23.2 μg/ml,AuNPs为92.1 μg/ml,利奈唑胺的最低MIC为2 μg/ml。AuNPs + 利奈唑胺和AgNPs + 利奈唑胺对生物膜形成的抑制活性平均提高了70%至80%。
与单独使用每种药物相比,当AgNPs和AuNPs与利奈唑胺联合使用时,它们的抗生物膜活性增强。